Biopharmaceutical multinational AstraZeneca on Thursday said the preliminary analysis of an ongoing safety and immunogenicity trial has indicated that Vaxzevria, when given as a third dose booster,......
If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India. IMAGE: Vials of the Covishield vaccine at a vaccination point in......
A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......
A coronavirus vaccine created by the University of Oxford appears safe and induces a strong immune response within the body, scientists announced on Monday after the first phase of human trials.......